Contact number
+852 3740 6888Share profile
Band 3
Provided by Paloma Wang
Corporate
Ms. Wang joined Skadden in 2018 from another leading law firm, where she was a partner.
Admitted in Hong Kong and England & Wales. Currently practising in Hong Kong.
Recent publications include:
2020 Corporate Governance Survey of Hong Kong-listed Biotech Companies, March 2021;
Are You Ready for a Hong Kong IPO?, September 2021; and
Hong Kong Encourages Listings by Foreign Companies, SPACs, Skadden Insights, January 2022.
Paloma Wang’s practice focuses on public listings and other corporate matters. She represents both issuers and underwriters in initial public offerings on the Hong Kong Stock Exchange, advising investors and corporates on private equity investments and counseling listed issuers on compliance, general corporate and regulatory matters.
Provided by Chambers
Paloma Wang wins acclaim for her expertise advising issuers and underwriters on biotech IPOs. She serves a host of clients from Skadden's base in Hong Kong.
